Emcure makes a premium of 31.5 per cent over IPO price

hanuman

Active member
EMCURE.jpg


Emcure Pharmaceuticals shares made a debut on July 10 after listing at Rs 1,325.05, a premium of 31.5 per cent over the issue price of Rs 1,008.

The successful Initial Public Offering (IPO) gathered significant investor interest. Emcure’s IPO ran from July 3 to July 5 and is a book-built issue valued at Rs 1,952.03 crores. The price band per share was Rs 960- Rs 1008.



The post appeared first on .
 
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock